• 5897 Citations
  • 37 h-Index
19942019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jun Ma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Intensity-Modulated Radiotherapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Chemoradiotherapy Medicine & Life Sciences
Nasopharyngeal carcinoma Medicine & Life Sciences
Induction Chemotherapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

  • 5897 Citations
  • 37 h-Index
  • 281 Article
  • 5 Review article
  • 3 Letter
2 Citations (Scopus)

10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma

Chen, L., Zhang, Y., Lai, S. Z., Li, W. F., Hu, W. H., Sun, R., Liu, L. Z., Zhang, F., Peng, H., Du, X. J., Lin, A. H., Sun, Y. & Ma, J., Jan 1 2019, In : Oncologist. 24, 1, p. e38-e45

Research output: Contribution to journalReview article

Intensity-Modulated Radiotherapy
Radiotherapy
Confidence Intervals
Survival
Therapeutics
1 Citation (Scopus)

ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma

Peng, H., Zhang, J., Zhang, P. P., Chen, L., Tang, L. L., Yang, X. J., He, Q. M., Wen, X., Sun, Y., Liu, N., Li, Y. Q. & Ma, J., Jan 8 2019, In : Journal of Experimental and Clinical Cancer Research. 38, 1, 11.

Research output: Contribution to journalArticle

Aryl Hydrocarbon Receptor Nuclear Translocator
Cyclin-Dependent Kinase 5
Cisplatin
Carcinogenesis
Cell Line
1 Citation (Scopus)

Clinical features and survival outcomes between ascending and descending types of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis

Yao, J. J., Qi, Z-Y., Liu, Z. G., Jiang, G. M., Xu, X. W., Chen, S. Y., Zhu, F. T., Zhang, W. J., Lawrence, W. R., Ma, J., Zhou, G. Q. & Sun, Y., Aug 1 2019, In : Radiotherapy and Oncology. 137, p. 137-144 8 p.

Research output: Contribution to journalArticle

Intensity-Modulated Radiotherapy
Intelligence
Survival
Neoplasms
Recurrence
1 Citation (Scopus)

Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial

Li, W. F., Chen, N. Y., Zhang, N., Hu, G. Q., Xie, F. Y., Sun, Y., Chen, X. Z., Li, J. G., Zhu, X. D., Hu, C., Xu, X. Y., Chen, Y. Y., Hu, W. H., Guo, L., Mo, H. Y., Chen, L., Mao, Y. P., Sun, R., Ai, P., Liang, S. B. & 15 others, Long, G. X., Zheng, B. M., Feng, X. L., Gong, X. C., Li, L., Shen, C. Y., Xu, J. Y., Guo, Y., Chen, Y. M., Zhang, F., Lin, L., Tang, L. L., Liu, M-Z., Ma, J. & Sun, Y., Jul 1 2019, In : International Journal of Cancer. 145, 1, p. 295-305 11 p.

Research output: Contribution to journalArticle

Induction Chemotherapy
Chemoradiotherapy
Randomized Controlled Trials
docetaxel
Survival

Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?

Yao, J. J., Jin, Y. N., Liu, Z. G., Liu, Q. D., Pei, X. F., Zhou, H. L., Zhang, W. J., Zhang, F., Lin, L., Lawrence, W. R., Wang, S. Y., Ma, J., Zhou, G. Q. & Sun, Y., Mar 1 2019, In : Therapeutic Advances in Medical Oncology. 11

Research output: Contribution to journalArticle

Open Access
Induction Chemotherapy
Chemoradiotherapy
Cisplatin
docetaxel
Neoplasm Metastasis